Detalhe da pesquisa
1.
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.
Haematologica
; 102(5): e203-e206, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28082342
2.
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Leukemia
; 36(7): 1870-1878, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562406